Results 201 to 210 of about 423,654 (332)

Eradication therapy for peptic ulcer disease in Helicobacter pylori-positive people.

open access: yesCochrane Database of Systematic Reviews, 2016
A. Ford   +4 more
semanticscholar   +1 more source

Nanomedicine for Oral Delivery: Strategies to Overcome the Biological Barriers

open access: yesSmall Methods, Volume 10, Issue 2, 22 January 2026.
Oral delivery is a preferred administration route for many clinical applications, valued for its strong patient compliance. In this review, how nanoparticles are engineered and deployed to overcome the gastrointestinal barriers that impede clinical translation of oral delivery formulations is examined.
Luke J. Kubiatowicz   +5 more
wiley   +1 more source

Peptic Ulcer Disease. [PDF]

open access: yesKorean J Helicobacter Up Gastrointest Res
Kim SH.
europepmc   +1 more source

Evidence-based clinical practice guidelines for peptic ulcer disease 2015

open access: yesJournal of gastroenterology, 2016
K. Satoh   +19 more
semanticscholar   +1 more source

Toxic Epidermal Necrolysis and Mortality: A Danish Cohort Study With 30 Years of Follow‐Up

open access: yesThe Journal of Dermatology, Volume 53, Issue 1, Page 35-40, January 2026.
ABSTRACT Toxic epidermal necrolysis (TEN) is a rare, life‐threatening dermatologic condition, typically triggered by medications. While increased short‐term mortality in this group is well documented, few studies have quantified this risk over extended follow‐up.
Ida M. Heerfordt   +5 more
wiley   +1 more source

Risk Factors of Hematological Toxicity of Mesothelioma Treatment—A Territory‐Wide Retrospective Study

open access: yesThoracic Cancer, Volume 17, Issue 2, January 2026.
We examined the prevalence and risk factors of hematological toxicities associated with mesothelioma treatment in this territory wide retrospective study in Hong Kong. We demonstrated that hematological toxicities were common in the treatment course of mesothelioma.
Wang Chun Kwok   +3 more
wiley   +1 more source

An exploratory analysis of 5‐alpha reductase inhibitors and risk of opioid use disorder among male Medicare beneficiaries receiving prescription opioid medications

open access: yesThe American Journal on Addictions, Volume 35, Issue 1, Page 46-52, January 2026.
Abstract Background Opioid use disorder (OUD) imposes a significant socioeconomic burden, highlighting the need for new interventions. Objective This study investigated whether exposure to 5‐alpha reductase inhibitors (5αRIs) is associated with a lower risk of developing OUD.
Abdelrahman G. Tawfik   +5 more
wiley   +1 more source

Various aspects of peptic ulcer in patients with liver cirrhosis

open access: diamond, 2018
Željka Savić   +5 more
openalex   +2 more sources

Heterogeneity in susceptibility to metronidazole among Helicobacter pylori isolates from patients with gastritis or peptic ulcer disease [PDF]

open access: bronze, 1996
Jan Weel   +5 more
openalex   +1 more source

Home - About - Disclaimer - Privacy